Literature DB >> 1680592

Molecular genetics of the debrisoquin-sparteine polymorphism.

F J Gonzalez1, U A Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1680592     DOI： 10.1038/clpt.1991.131

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  31 in total

1.  MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press.

Authors:  A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-02-20       Impact factor: 4.530

Review 2.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

3.  No association between CYP2D6 polymorphisms and personality trait in Japanese.

Authors:  Kumiko Iwashima; Norio Yasui-Furukori; Ayako Kaneda; Manabu Saito; Taku Nakagami; Yasushi Sato; Sunao Kaneko
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

Review 4.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

5.  Synthetic strategies to lower affinity for CYP2D6.

Authors:  R C Halliday; B C Jones; B K Park; D A Smith
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

6.  Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.

Authors:  Siew Hua Gan; Rusli Ismail; Wan Aasim Wan Adnan; Wan Zulmi
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 7.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

Review 8.  Pharmacokinetic optimisation of the treatment of osteoarthritis.

Authors:  K J Skeith; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

9.  Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian population.

Authors:  C Mura; N Gerard; M Vincent-Viry; M M Galteau; E Jacqz-Aigrain; R Krishnamoorthy
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

10.  Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.

Authors:  D Wu; S V Otton; B A Sproule; U Busto; T Inaba; W Kalow; E M Sellers
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.